fenproporex has been researched along with Obesity in 7 studies
*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correr, CJ; Fernandez-Llimos, F; Lucchetta, RC; Otuki, MF; Pontarolo, R; Radominski, RB; Riveros, BS | 1 |
| Boguszewski, CL; Cunha, DR; do Desterro de Figueiredo, M; dos Santos, CM; Radominski, R; Suplicy, H | 1 |
| de Oliveira, AC; Paumgartten, FJ; Pereira, SS | 1 |
| Cardoso, MR; Ferreira, GK; Gomes, LM; Jeremias, IC; Martinello, OB; Morais, MO; Quevedo, J; Rezin, GT; Streck, EL; Valvassori, SS | 1 |
| de los Angeles Saavedra, M; Hernández, A | 1 |
| Autissier, N; Dumas, P; Loireau, A; Michel, R | 1 |
| Boguszewski, CL; De Almeida, SM; Niclewicz, PA; Radominski, RB; Rodrigues, AM; Suplicy, Hde L | 1 |
1 review(s) available for fenproporex and Obesity
| Article | Year |
|---|---|
Safety and efficacy of fenproporex for obesity treatment: a systematic review.
Topics: Amphetamine; Amphetamines; Anti-Obesity Agents; Humans; Obesity; Placebos | 2016 |
2 trial(s) available for fenproporex and Obesity
| Article | Year |
|---|---|
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss | 2014 |
The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.
Topics: Adolescent; Adult; Amphetamines; Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Leptin; Middle Aged; Obesity; Orlistat; Weight Loss | 2002 |
4 other study(ies) available for fenproporex and Obesity
| Article | Year |
|---|---|
Diethylpropion and mazindol: An end to the discussion?
Topics: Amphetamines; Appetite Depressants; Brazil; Cyclobutanes; Diethylpropion; Drug Approval; Humans; Mazindol; Obesity; Risk Assessment; Treatment Outcome | 2017 |
Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats.
Topics: Adolescent; Adult; Amphetamines; Animals; Brain; Central Nervous System Stimulants; Child; Citrate (si)-Synthase; Citric Acid Cycle; Creatine Kinase; Electron Transport; Energy Metabolism; Humans; Malate Dehydrogenase; Male; Obesity; Rats; Rats, Wistar; Succinate Dehydrogenase | 2011 |
[Short-term treatment of obesity: comparison between anorexigens and behavior modification].
Topics: Adult; Amphetamines; Appetite Depressants; Behavior Therapy; Body Weight; Diet, Reducing; Female; Humans; Middle Aged; Obesity | 1984 |
Thyroid status and effects of 3,5,3' triiodothyroacetic acid and fenproporex in genetically lean and obese female rats.
Topics: Amphetamines; Animals; Appetite Depressants; Body Weight; Eating; Female; Lipids; Obesity; Rats; Thyroid Gland; Thyroid Hormones; Triiodothyronine | 1980 |